Injective (INJ) was among the top-performing altcoins on Monday as bullish sentiment swept the cryptocurrency market.
The token traded above $13.60, lifted by renewed investor confidence following Bitcoin’s surge past $105,000.
With improving macroeconomic sentiment and regulatory progress fueling broader market momentum, analysts suggest Bitcoin could challenge new all-time highs in the near term.
That backdrop has helped rotate capital into altcoins, with projects like Injective benefiting from increased speculative interest.
A layer-1 blockchain focused on decentralized finance and real-world asset tokenization, Injective is attracting attention as narratives around scalability and growing use cases gain traction.
Injective price extends gains beyond $10
The price of Injective (INJ) rose 7% over the past 24 hours, advancing as major altcoins such as Ethereum, BNB and Solana broke key levels.
INJ climbed after recently moving past the $10 barrier.
At the time of writing, it was trading around $13.62. The token reached a high of $14.29 on May 12, 2025, marking its highest level since late February.
Amid the price uptick, Injective’s market capitalization rose to $1.37 billion, while 24-hour trading volume remained moderate at $172 million.
Having surged 46% over the past seven days and 67% across the last 30 days, overall market interest suggests upside momentum could persist.
Bitcoin rally and RWA tokenization push INJ higher
While Bitcoin’s rally has bolstered confidence across the market, additional catalysts for INJ include strong institutional demand within the real-world asset (RWA) ecosystem.
Tokenization serves as a major tailwind for Injective, with recent industry analysis highlighting how the sector enhances INJ’s appeal.
The recent bull cycle has driven explosive growth across DeFi, play-to-earn gaming, memecoins and AI-related tokens.
Now, analysts say that as those segments expand, RWA market growth positions blockchains like Injective squarely in focus.
The Injective network, optimized for tokenizing traditional assets such as equities, stablecoins and commodities, stands out as a potential beneficiary.
Investors scouting opportunities on tokenization-friendly chains increasingly view Injective as a platform of choice.
Greater RWA adoption could further amplify INJ’s price momentum.
Injective price technical outlook
From a technical perspective, INJ’s daily chart presents a bullish picture.
The daily Relative Strength Index (RSI) currently sits in overbought territory.
However, it is not extended enough to rule out further upside.
In the event of a pullback, INJ may find support around $11.05 and $10.22.
This scenario aligns with the Moving Average Convergence Divergence (MACD), which shows a bullish crossover.
The histogram indicates upward momentum. If that momentum continues, upside targets would include $16 and then $20.